Remove drug-diversion-in-long-term-care-case-examples
article thumbnail

Drug Diversion in Long Term Care – Case Examples

Med Ed 101

As a consultant pharmacist, I have encountered numerous scenarios of drug diversion in long term care and assisted living settings. The post Drug Diversion in Long Term CareCase Examples appeared first on Med Ed 101.

article thumbnail

The rise of prescription drug abuse and drug diversion

pharmaphorum

As prescription drug abuse has grown in the US and Europe, the diversion of such treatments from legitimate sources has also increased. Ben Hargreaves speaks to an expert in the area to learn how drug diversion occurs, and how it can be countered. Why drug diversion represents a challenge.

Hospitals 105
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

How to take care of your BIPOC patients

The Checkup by Singlecare

As a pharmacist, it’s important to recognize that not all patients have the same needs or circumstances and to adapt your care accordingly. A long history of medical racism in the U.S. continues to impact BIPOC individuals and contribute to documented racial and ethnic disparities in health care.

article thumbnail

Economist Impact: World Cancer Series – pharmaphorum in attendance, day one (part ii)

pharmaphorum

To continue with pharmaphorum’s coverage of Day One of The Economist’s 8th Annual World Cancer Series congress in Brussels, Belgium this week – where the foci were “innovation, equity, and excellence” – after the opening addresses came a panel on the priorities for innovation and excellence in cancer care within Europe.

article thumbnail

Why AI equity is the next step for transformational pharma

pharmaphorum

AI can be transformative for all areas of healthcare, but often these systems are built off biased datasets that don’t reflect the true diversity of the general public – leading to approaches that only work for specific populations. Because of this, there are increasing calls for ‘AI Equity’ to be promoted across the industry.

article thumbnail

Drug development and working with specialised Rare Disease networks

pharmaphorum

However, despite the work still left to be done, there are now a growing number of treatments in the pipeline and 2020 proved to be a remarkable year for orphan drug approvals, with the US FDA approving more orphan designated treatments than non-orphan drugs. Sub-heading: The challenges in serving patients.

article thumbnail

Challenges & Opportunities in Emerging Digital Health Technologies

ISPE

Digital health is transforming the health care landscape through new technologies and platforms in patient care management, conducting of clinical trials, patient data collection, and the diagnosis and treatment of disease. Challenges & Opportunities in Emerging Digital Health Technologies. Trudy Patterson. Thu, 10/27/2022 - 16:20.